Diagnostic tests for tuberculous lymphadenitis: fine needle aspirations using tissue culture in mycobacteria growth indicator tube and tissue PCR



Similar documents
TUBERCULOSIS PLEURAL EFFUSION - MANAGEMENT

Paediatrica Indonesiana. Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation

Clinical Scenarios In Childhood TB. Josefina Cadorna Carlos M.D., FPPS, FPIDSP, FSMID Associate Professor of Pediatrics U E R M M M C

Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008)

Appendix B: Provincial Case Definitions for Reportable Diseases

The Diagnosis of Cancer in the Pathology Laboratory

Cervical lymphadenopathy

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA. Minoo Ghajar Orange County Public Health Laboratory

OBJECTIVES By the end of this segment, the community participant will be able to:

Nicole Kounalakis, MD

Originally published as:

2011 NTP Paediatric guidelines update- final draft

D. FREQUENTLY ASKED QUESTIONS

Tuberculosis Exposure Control Plan for Low Risk Dental Offices

Laboratory Techniques for the Diagnosis of TB what s available? Dr. Annette Jepson

Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma

Cytology of Lymph Nodes

Perils and Pitfalls in Clinical Trials of Diagnostic Tests for Tuberculosis. Richard O Brien, MD Foundation for Innovative New Diagnostics Geneva

LYMPHOMA IN DOGS. Diagnosis/Initial evaluation. Treatment and Prognosis

Pleural and Pericardial fluids a one year analysis

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Uses and Abuses of Pathology in Asbestos-exposed Populations

Health Protection Agency position statement on the use of Interferon Gamma Release Assay (IGRA) tests for Tuberculosis (TB)

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna

WHICH SAMPLES SHOULD BE SUBMITTED WHEN LYMPHOID NEOPLASIA IS SUSPECTED?

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

IMA Knowledge June, 2015

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

International Journal of Case Reports in Medicine

MATERIALS AND METHODS: Aim of the study was to study the cytomorphological spectrum of breast lesions on Fine needle aspiration cytology (FNAC).

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

Learning about Mouth Cancer

DRAFT FOR CONSULTATION

AIR FORCE REPORTABLE EVENTS GUIDELINES & CASE DEFINITIONS

Appendix E-- The CDC s Current and Proposed Classification System for HIV Infection

YOUR LUNG CANCER PATHOLOGY REPORT

DIAGNOSTIC TEST OF BOVINE TUBERCULOSIS

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

Guideline for the Imaging of Patients Presenting with Breast Symptoms incorporating the guideline for the use of MRI in breast cancer

SARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:

BREAST CANCER PATHOLOGY

7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Pediatric Oncology for Otolaryngologists

Epi procolon The Blood Test for Colorectal Cancer Screening

Chapter 2 Staging of Breast Cancer

THE NATURAL HISTORY OF PULMONARY TUBERCULOSIS

E xudative pleural effusions are common in the clinical practice of both respiratory

Pregnancy and Tuberculosis. Information for clinicians

CDC TB Testing Guidelines and Recent Literature Update

Explanation of your PAP smear

PEDIATRIC TUBERCULOSIS. Hot topics / Unresolved issues in Clinical Practice

Breast Implants: Local Complications and Adverse Outcomes

NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME

Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)

Guidelines for TB Blood Testing. Minnesota Department of Health TB Prevention and Control Program June 2011

Provider Reimbursement for Women's Cancer Screening Program

PATHOLOGY DEPARTMENTS AT GRADUATE MEDICAL EDUCATION TEACHING INSTITUTIONS

Veterinary Testing. Classes of Test

Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD

CERVICAL MEDIASTINOSCOPY WITH BIOPSY

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Master of Physician Assistant Studies Course Descriptions for Year I

Fungal Infection in Total Joint Arthroplasty. Dr.Wismer Dr.Al-Sahan

Tuberculosis: FAQs. What is the difference between latent TB infection and TB disease?

Interesting Case Series. Periorbital Richter Syndrome

Approach to Masses of the Head and Neck

Lung Cancer Center: How to Achieve JCI

Corporate Overview. April 2014 OTCQB: LCDX

LEARNING OUTCOMES. Identify children at risk of developing TB disease. Correctly manage and refer children suspected of TB. Manage child contacts

FRIEND TO FRIEND CPT CODES Diagnostic digital breast tomosynthesis, unilateral (list separately in addition to code for primary procedure)

Tuberculosis in Children and Adolescents

Recommendations for cross-sectional imaging in cancer management, Second edition

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

Recurrent or Persistent Pneumonia

MANAGEMENT OF TUBERCULOSIS IN PRISONS: Guidance for prison healthcare teams

HIV/AIDS. HIV- Human Immunodeficiency Virus. AIDS immume system severely damaged

Pediatric Latent TB Diagnosis and Treatment

Genetic Testing in Research & Healthcare

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

Frozen Section Diagnosis

Integumentary System Individual Exercises

Blood, Lymphatic and Immune Systems

The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion

Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

Course Outline and Syllabus for Students

Use of Nucleic Acid Amplification Tests in TB patients in California

Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015

Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA

An individual is considered an incident case only once per lifetime.

CIBMTR Infection Data and the New Infection Inserts.

PLASTIC SURGERY RESIDENTS HANDBOOK

Transcription:

Asian Biomedicine Vol. 4 No. 5 October 2010; 787-792 Technical report Diagnostic tests for tuberculous lymphadenitis: fine needle aspirations using tissue culture in mycobacteria growth indicator tube and tissue PCR Pakpoom Supiyaphun a, Somying Tumwasorn b, Nibondh Udomsantisuk b, Somboon Keelawat c, Wilailuck Songsrisanga a, Punjapon Prasurthsin b, Ajcharaporn Sawatpanich b a Department of Otolaryngology, b Department of Microbiology, c Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand Background: The diagnosis of tuberculous lymphadenitis (TBLN) ranges from therapeutic diagnosis to open biopsy with tissue culture. The open biopsies are accepted as the gold standard to diagnose TBLN, but it requires skin incision that leaves unwanted scars. Objective: Test the sensitivity and specificity of fine needle aspiration (FNA) using tissue culture in mycobacteria growth indicator tube (MGIT) and tissue polymerase chain reaction (PCR) for comparison with open biopsy using tissue culture. Subject and methods: Forty patients with clinically suspected cervical tuberculous lymphadenitis were recruited at King Chulalongkorn Memorial Hospital. The patients underwent FNA followed by open biopsies either excisional or incisional. Specimens from FNA were collected for tissue culture in MGIT and for tissue PCR. The specimens from open biopsies were divided into two portions for tissue culture in MGIT (the gold standard) and for hispathology. Results: FNA for tissue culture in MGIT had a moderate sensitivity (65%) but high specificity (83%) (73% positive and 76% negative predictive value). FNA for tissue PCR had a moderate sensitivity (53%) but very high specificity (96%) (90% positive and 73% negative predictive values). Combination of either FNA for tissue culture or FNA tissue PCR revealed an increase in sensitivity and specificity to 83.6% and 80.0%, respectively. However, a combination of both FNA for tissue culture and FNA tissue PCR revealed a decrease in sensitivity (34.5%) but a highly increase in specificity (99.0%). Conclusion: Either the FNA using tissue culture in MGIT or tissue PCR had a moderate sensitivity but high specificity. FNA using tissue culture or FNA tissue PCR may be used as an alternative test for diagnosis TBLN. The techniques may replace the open biopsies because of its effectiveness and low complication rate. Keywords: FNA, MGIT, PCR, tuberculosis, lymphadenitis The incidence of tuberculosis (TB) rises significantly, partly from the widespread human immunodeficiency virus (HIV) infection [1], and partly from global migration of infected individuals. Tuberculous lymphadenitis (TBLN) is the most common form of extrapulmonary TB [2], and one of the most frequent causes of lymphadenopathy (30-52%) [3]. Correspondence to: Pakpoom Supiyaphun MD, Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok 10330, Thailand. E-mail: cu_ ent@hotmail.com In general, TBLN is differentiated from other granulomatous lymphadenopathy such as sarcoidosis, lymphoma or sarcoma, viral or bacterial adenitis, fungal infection, toxoplasmosis, and cat-scratch fever that mimics the diagnosis of TB by cytology and/or histopathology [4]. It is hard to distinguish TBLN from atypical mycobacterium infection which needs surgical removal [5]. Therefore, correct diagnosis should be used for proper management. The definite diagnosis of TBLN is made through bacterial cultures. The sensitivity of mycobacterial isolation is very low, and the isolation process takes a

788 P. Supiyaphun, et al. long time. For this reason, the treatment of cervical TBLN usually begins with the histological diagnosis. However, surgical biopsy through skin incision leaves unwanted scar tissues in the neck, causing aesthetic problems. Moreover, there is a possibility of long-term drainage problems through the incision line [6]. Recently, diagnosis of TBLN using fine-needle aspiration cytology (FNAC) in cervical lymph nodes has been widely used in endemic areas. This method can avoid unwanted effects of surgical biopsies, but the absence of specific cytologic findings of granulomatous lymphadenitis or negative acid-fast bacilli (AFB) smears require additional open biopsy or repeated FNAC. The diagnostic efficacy of FNAC has the sensitivity of only 52.9% and specificity of 100% [7]. It is very variable between institutions. Thus, this method has limitation in clinical situations. With recent advances in molecular diagnosis using polymerase chain reaction (PCR) and in culture methods using mycobacteria growth indicator tube (MGIT), new techniques have been introduced to identify mycobacterium TB more easily and quickly. These techniques may give a better diagnostic outcome. In this study, we evaluated the efficacy of fine needle aspiration (FNA) using tissue PCR and tissue culture in the MGIT as the diagnostic tools for cervical TBNL and compared the results of tissue culture with open-biopsies. Patients and method This prospective and diagnostic study was carried out at King Chulalongkorn Memorial Hospital between August 2003 and November 2006. The study was approved by the Ethics Committee of the Faculty of Medicine, Chulalongkorn University. Forty patients (4 men, 36 women) with cervical lymphadenopathy were recruited for this study. Their ages ranged between 18-69 years (mean ± standard deviation: 34±8 years). The patients signed informed consents. Inclusion criteria included patients presented with mobile, painless cervical lymphadenopathy with diameter greater than 1 cm. There was no evidence of head and neck cancer on physical examination and no recent upper airway infection. The chest X-ray was normal. There was no spontaneous regression of cervical lymphadenopathy after two months of observation. Out-patients FNA cytology reports revealed the epithelioid cell granuloma and caseation necrosis. Exclusion criteria excluded any patients who either were treated with the anti TB drugs, or have cancer or any systemic diseases. Diagnostic procedure All diagnostic procedures were carried out in the operating room, under sterile technique. The FNAs were performed before open biopsies. Specimens from FNAs are divided into two portions as follows. One was immediately put in sterile bottle filled with 0.5 ml sterile normal saline solution and sent to the laboratory for tissue PCR (High Pure PCR Template Preparation Kit; Roche, Mannheim, Germany), according to the standard technique described elsewhere [8]. Another was immediately inoculated into Mycobacteria Growth Indicator tube or MGIT (Becton, Dickinson U.K. Limited, Oxford, U.K.) for tissue culture [9]. Following FNAs, the open-biopsy by either total excision or incisional was carried out. The specimens were divided for histopathological examination and for tissue culture in the MGIT. Results The demographic data, histopathology, tissue cultures in MGIT and tissue PCR obtained from both FNA and open-biopsies and histopathological diagnoses are shown in Table 1. Histopathological diagnoses of all 40 open-biopsy specimens revealed the caseating granulomatous lymphadenitis in 14 cases (35.0%), necrotizing granulomatous lymphadenitis in 17 cases (42.5%), histiocytic necrotizing lymphadenitis in three cases (7.5%), and necrotic granulomatous inflammation in four cases (10.0%). All but one cases with a diagnosis of granulomatous lymphadenitis/inflammation demonstrated negative AFB staining (34 out of 35 cases). Moreover, even in 14 cases diagnosed as caseating granulomatous lymphadenitis, only one case showed a positive AFB. Seventeen cases showed positive results while 23 cases were negative. Ten out of 17 cases (58.8%) positive result cases showed positive FNA-tissue cultures. However, four out of 23 cases (17.4%) with negative biopsy-tissue cultures reciprocally showed the positive FNA-tissue cultures (Table 2). Then, the sensitivity, specificity, and positive and negative predictive values of the FNA-tissue culture in the MGIT were 65%, 83%, 73%, and 76%, respectively.

Vol. 4 No. 5 October 2010 Diagnostic tests for tuberculous lymphadenitis 789 Table 1. Histopathology, FNA-tissue for MGIT and PCR and open-biopsy for MGIT in 40 patients (P = positive, N = negative). Subject Age Surgical pathology FNA tissue Excisional tissue (year) with AFB stain MGIT PCR culture MGIT 1 28 Caseating granulomatous Lymphadenitis; AFB+ve N P P 2 42 Caseating granulomatous 3 34 Caseating granulomatous 4 26 Caseating granulomatous 5 21 Necrotizing granulomatous 6 32 Reactive lymphoid hyperplasia N N N 7 51 Caseating granulomatous 8 31 Caseating granulomatous Lymphadenitis; AFB-ve N N P 9 26 Reactive lymphoid hyperplasia N N N 10 20 Caseating granulomatous 11 39 Caseating granulomatous 12 33 Caseating granulomatous 13 30 Caseating granulomatous Lymphadenitis; AFB-ve N P P 14 40 Caseating granulomatous Lymphadenitis; AFB-ve N P P 15 33 Caseating granulomatous 16 43 Caseating granulomatous 17 20 Reactive lymphoid hyperplasia N N N 18 33 Histiocytic necrotizing lynphadenitis N N N 19 24 Caseating granulomatous 20 34 Histiocytic necrotizing lymphadenitis N N N 21 32 Necrotic granulomatous Inflammation; AFB-ve P N P 22 29 Necrotic granulomatous Inflammation; AFB-ve N P N 23 42 Necrotic granulomatous Inflammation; AFB-ve N N N 24 26 Necrotic granulomatous Inflammation; AFB-ve N N N 25 27 Necrotizing granulomatous 26 49 Necrotizing granulomatous 27 29 Necrotizing granulomatous

790 P. Supiyaphun, et al. Table 1. Histopathology, FNA-tissue for MGIT and PCR and open-biopsy for MGIT in 40 patients (P = positive, N = negative) (continued). Subject Age Surgical pathology FNA tissue Excisional tissue (year) with AFB stain MGIT PCR culture MGIT 28 34 Necrotizing granulomatous 29 27 Necrotizing granulomatous 30 44 Necrotizing granulomatous 31 47 Necrotizing granulomatous Lymphadenitis; AFB-ve N N P 32 44 Necrotizing granulomatous 33 57 Necrotizing granulomatous 34 35 Necrotizing granulomatous Lymphadenitis; AFB-ve N P P 35 45 Necrotizing granulomatous 36 69 Necrotizing granulomatous 37 24 Necrotizing granulomatous 38 49 Necrotizing granulomatous 39 25 Necrotizing granulomatous 40 18 Necrotizing granulomatous Table 2. Culture results vs. FNA for culture. Culture positive Culture negative FNA culture +ve 11 4 FNA culture -ve 6 19 Sensitivity= 65%, Specificity = 83%, Positive predictive value = 73%, Negative predictive value = 76%. The FNA-tissue PCRs were compared with the gold standard. For 17 cases with a positive open-biopsy tissue culture, only nine cases yields the positive PCR (53%). However, for 23 cases with negative tests for the gold standard, 22 cases showed a negative PCR (96%). The sensitivity, specificity, and positive and negative predictive values of the FNA-tissue PCR were 53%, 96%, 90%, and 73%, respectively (Table 3). When these two diagnostic tests (FNA-tissue culture and FNA-tissue PCR) were combined, we obtained the results as follows (Table 4). 1) For combination of only either tests, the sensitivity and specificity were 83.6% and 80.0%, respectively. 2) For combination of both tests together, the combined sensitivity and specificity were 34.5% and 99.0%, respectively.

Vol. 4 No. 5 October 2010 Diagnostic tests for tuberculous lymphadenitis 791 Table 3. Culture results vs. FNA for PCR. Culture positive Culture negative FNA for PCR +ve 9 1 FNA for PCR -ve 8 22 Sensitivity= 53%, Specificity = 96%, Positive predictive value = 90%, Negative predictive value = 73%. Table 4. Sensitivity and specificity; FNA for culture or FNA for PCR. Sensitivity Specificity FNA for culture 65.0% 83.0% FNA for PCR 53.0% 96.0% FNA culture or FNA PCR* 83.6% 80.0% FNA culture and FNA PCR** 34.5% 99.0% *combined Either FNA culture or FNA PCR, **combined both FNA culture and FNA PCR Discussion It is very difficult to diagnosis TBLN definitely. It ranges from so-called therapeutic diagnosis to openbiopsy with histopathology and tissue culture [9]. The open biopsies with tissue culture are accepted as the gold standard to diagnose TBLN. However, it requires skin incision that leaves the unwanted scars. Moreover, histopathological examination, even using AFB staining, frequently leads to misdiagnoses of TBLN. In fact, in our experiment, the histopathology reports were often difficult to distinguish caseating granulomatous lymphadenitis and necrotizing granulomatous lymphadenitis. Moreover, the AFB staining was not necessarily helpful. It yielded only one AFB-Positive from total 40 cases or otherwise one from 17 cases with positive open-biopsy tissue culture in MGIT. Since the histopathology with AFB staining is not a good indicator for TBLN, it is important to develop tests with high sensitivity and specificity but that dose less invasion and provided a definite diagnosis. In this study, we used open-biopsy tissue culture of Mycobacterium tuberculosis by MGIT technique as the gold standard. Since the FNA technique did not require skin incision, we could not obtain histopathology but we did obtain FNA tissue for culture and PCR. Compared to the gold standard, the sensitivity, specificity, and positive and negative predictive values of FNA-tissue culture were 65%, 83%, 73%, and 76%, respectively. The sensitivity, specificity, positive and negative predictive values of FNA-tissue PCR were 53%, 96%, 90%, and 73%, respectively. The low sensitivity of either methods means that any of them cannot be a good screening diagsnotic test for TB lymph node. However, if we combine the test sensitivity of either FNA tissue culture or FNA tissue PCR, the results are higher (83.6%) as shown in Table 4. Therefore, we should do both tests and look for the positivity of any tests that fits for the screening. However, if we deen both tests positive, it is not good for screening. This combination should be a good confirmed test (combined specificity: 99%). Although tissue PCR is a less time-consuming test (one week) compared to the culture technique (MGIT about three weeks), PCR cannot give information about susceptibility to antimicrobial agents. Therefore, the culture techniques, especially the MGIT method, still remains essential in every case. In our study, four patients had false positive for FNA tissue culture. It is difficult to explain these false positive tests. However, the tissue obtained from FNA is a very small amount compared to open-biopsy specimen. It is likely that the presence of the contamination with resistant micro-organism during FNA may induce changes in MGIT indicator and not reflect the true TBLN. In our FNA-tissue PCR group, one patient had a false positive test. According to Narita et al. [10], PCR technique was able to detect a minor trace of DNA in lymph node specimens. These specimens may contain only nonviable TBNL cells that cannot be detected by the culture technique.

792 P. Supiyaphun, et al. Conclusion TBLN is hard to diagnose by histopathology with or without ABF staining. For diagnoses of TBLN, the authors suggest FNA tissue culture in MGIT combined with FNA tissue PCR. The combination of either test gives a good screening result without any need of skin incision that leaves unwanted scars. Acknowledgement The authors would like to thank to Ratchadapisek Sompotch Fund, Faculty of Medicine, Chulalongkorn University for providing our funding supports. The authors have no conflict of interest to declare. References 1. Williams R, Douglas-Jones T. Mycobacterium marched back. J Laryngol Otol. 1995; 109:5-13. 2. Appling D, Miller RH. Mycobacterial cervical lymphadenopathy 1981 update. Laryngoscope. 1981; 91:1259-66. 3. Gupta AK, Nayar M, Chandra M. Critical appraisal of FNAC in tuberculous lymphadenitis. Acta Cytol. 1992; 36:391-4. 4. Gupta SK, Chugh TD, Sheikh ZA, al-rubah NA. Cytodiagnosis of tuberculous lymphadenitis: a correlative study with microbiologic examination. Acta Cytol. 1993; 37:329-32. 5. Akhtar J, Howatson AG, Raine PA. Atypical mycobacterial in childhood: a surgical disease. J R Coll Surg Edinb. 1997; 42:110-1. 6. Kanlikama M, Gkalp A. Management of mycobacterial cervical lymphadenitis. World J Surg. 1997; 21:516-9. 7. Baek CH, Kim SI, Ko YH, Chu KC. Polymerase chain reaction detection of Mycobacterium tuberculosis from fine-needle aspirate for the diagnosis of cervical tuberculous lymphadenitis. Laryngoscope. 2000; 110: 30-4. 8. Hirunwiwatkul P, Tumwasorn S, Chantranuwat C, Sirichai U. A comparative study of diagnostic tests for tuberculous lymphadenitis: PCR vs histopathology and clinical diagnosis. J Med Assoc Thai. 2002; 85: 320-6. 9. Chuchottaworn C, Kumnuankun M, Boonyasopan J. Evaluate on of mycobacterial growth indicator tube (MGIT) for culturing mycobacteria from clinical specimens. Thai J Tuberc Chest Dis. 1997; 18:295-301. 10. Narita M, Shibata M, Togashi T, Kobayashi H. Polymerase chain reaction for detection of mycobacterium tuberculosis. Acta Paediatr. 1992; 81: 141-4.